Estrogen was recently found to differentially modulate nAChR subtype [5], and the expression of nAChR by breast cancers may similarly provide a new target for breast cancer therapies, whereas nicotine, a ligand for nAChR, was found to have stimulated breast cancer growth. This evidence concerns the gene CHRNA4 and breast carcinoma.